Cross-Regulation Between DNA Methylation and Circadian Clock Reprogramming in Ovarian Cancer: Mechanistic Insights, Biomarker Potential, and Therapeutic Implications.

Xing M, Zhou C, Tang Y, Xu S, Zhou S, Liu W, Liu H

Open source

DOI
10.1002/ijc.70704
Published
2026 Aug 19
Container
International journal of cancer
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ijc.70704,
  title = {Cross-Regulation Between DNA Methylation and Circadian Clock Reprogramming in Ovarian Cancer: Mechanistic Insights, Biomarker Potential, and Therapeutic Implications.},
  author = {Xing M and Zhou C and Tang Y and Xu S and Zhou S and Liu W and Liu H},
  year = {2026},
  journal = {International journal of cancer},
  doi = {10.1002/ijc.70704},
  url = {https://doi.org/10.1002/ijc.70704}
}

RIS

TY  - JOUR
TI  - Cross-Regulation Between DNA Methylation and Circadian Clock Reprogramming in Ovarian Cancer: Mechanistic Insights, Biomarker Potential, and Therapeutic Implications.
AU  - Xing M
AU  - Zhou C
AU  - Tang Y
AU  - Xu S
AU  - Zhou S
AU  - Liu W
AU  - Liu H
PY  - 2026
JO  - International journal of cancer
DO  - 10.1002/ijc.70704
UR  - https://doi.org/10.1002/ijc.70704
ER  - 

APA

M, X., C, Z., Y, T., S, X., S, Z., W, L., & H, L. (2026). Cross-Regulation Between DNA Methylation and Circadian Clock Reprogramming in Ovarian Cancer: Mechanistic Insights, Biomarker Potential, and Therapeutic Implications.. International journal of cancer. https://doi.org/10.1002/ijc.70704

Source records